In addition, hypermethylation of both genes in cfDNA extracted from serum, as well as of the additional candidate hypermethylation markers CCDC181 and HAPLN3, was highly specific for patients with PC compared to patients with BPH. Here, HAPLN3 is linked to benign prostatic hyperplasia.